| 3-BROMO-5-CYCLOPROPYLPYRIDINE |
3-溴-5-环丙基吡啶 |
1044210-57-2 |
| tert-butyl (R)-3-formylpyrrolidine-1-carboxylate |
(3R)-3-甲酰基-1-吡咯烷甲酸叔丁酯 |
191347-94-1 |
| 1-(3-HydroxyMethyl-pyrrolidin-1-yl)-ethanone |
1-(3-HydroxyMethyl-pyrrolidin-1-yl)-ethanone |
191347-96-3 |
| XC-DAPOL-CPBA (>90%) |
XC-DAPOL-CPBA (>90%) |
191231-97-7 |
| 2-bromo-1-(3-fluoropyridin-2-yl)ethanone |
2-溴乙酰基-3-氟吡啶 |
1044270-51-0 |
| trace amine receptor 1 |
TAAR1 |
1043495-96-0 |
| 2-Amino-7-chloroquinazoline |
2-氨基-7-氯喹唑啉 |
190274-08-9 |
| 2-Amino-5-chloroquinazoline |
2-Amino-5-chloroquinazoline |
190273-70-2 |
| BOC-DAB-OTBU HCL |
(S)-2-叔丁氧羰基氨基-4-氨基丁酸叔丁酯 |
190447-69-9 |
| (1E)-D-Glucose hydrazone |
(1E)-D-葡萄糖腙 |
190259-02-0 |
| 4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-chloroaniline |
4-([1,2,4]三唑并[1,5-A]吡啶-7-基氧基)-3-氯苯胺 |
1033810-73-9 |
| L-Phenylalanine, 4-(2-aMino-6-chloro-4-pyriMidinyl)-N-[(1,1-diMethylethoxy)carbonyl]- |
(S)-3-[4-(2-氨基-6-氯嘧啶-4-基)苯基]-2-[(叔丁氧羰基)氨基]丙酸 |
1033804-86-2 |
| (S)-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)-2-(tert-butoxycarbonyl)propanoic acid |
(2S)-2-[(叔丁氧羰基)氨基]-3-[4-[2-氨基-6-[[(1R)-1-[4-氯-2-(3-甲基吡唑-1-基)苯基]-2,2,2-三氟乙氧基]嘧啶-4-基]苯基丙酸 |
1033805-27-4 |
| BOHEMINE |
BOHEMINE |
189232-42-6 |
| ETHYL 2-HYDROXY-4-PHENYLPYRIMIDINE-5-CARBOXYLATE |
4-苯基-2-羟基嘧啶-5-羧酸乙酯 |
188781-06-8 |
| 5-Pyrimidinecarbonylchloride,2-chloro-4-methyl-(9CI) |
5-Pyrimidinecarbonylchloride,2-chloro-4-methyl-(9CI) |
188781-13-7 |
| 4-CHLORO-6-ETHYLQUINOLINE |
4-氯-6-乙基喹啉 |
188758-77-2 |
| 5-(2-(Benzenesulfonyl)Vinyl)-3-(1-Methylpyrrolidin-2(R)-ylmethyl)-1H-Indole Hydr |
5-(2-(Benzenesulfonyl)Vinyl)-3-(1-Methylpyrrolidin-2(R)-ylmethyl)-1H-Indole Hydr |
188113-69-1 |
| 3-Pyridinecarboxylic acid, 5-chloro-6-(1-methylethoxy)- |
5-氯-6-(1-甲氧基)-3-吡啶羧酸 |
187401-45-2 |
| (S)-2-NITRO-6,7-DIHYDRO-5H-IMIDAZO[2,1-B][1,3]OXAZIN-6-OL |
(S)-2-硝基-6,7-二氢-5H-咪唑并[2,1-B][1,3]恶嗪-6-醇 |
187235-08-1 |
QQ
微信
